114 related articles for article (PubMed ID: 20857703)
21. [The role of external radiotherapy in the treatment of medullary carcinoma of the thyroid].
Costa MA; Sousa O; Azevedo I; Castro C; Fernandes T; Vieira E
Acta Med Port; 1998 Jun; 11(6):539-42. PubMed ID: 9773532
[TBL] [Abstract][Full Text] [Related]
22. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.
Dinneen SF; Valimaki MJ; Bergstralh EJ; Goellner JR; Gorman CA; Hay ID
J Clin Endocrinol Metab; 1995 Jul; 80(7):2041-5. PubMed ID: 7608252
[TBL] [Abstract][Full Text] [Related]
23. [Type of surgery for 147 patients with medullary carcinoma of the thyroid].
Huang CP; Zhu YX; Tian AL
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):490-2. PubMed ID: 14575577
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma.
Modigliani E
Curr Ther Endocrinol Metab; 1994; 5():112-7. PubMed ID: 7704692
[No Abstract] [Full Text] [Related]
25. Medullary thyroid carcinoma: multivariate analysis of prognostic factors influencing survival.
Peixoto Callejo I; Américo Brito J; Zagalo CM; Rosa Santos J
Clin Transl Oncol; 2006 Jun; 8(6):435-43. PubMed ID: 16790397
[TBL] [Abstract][Full Text] [Related]
26. Management and outcome of recurrent well-differentiated thyroid carcinoma.
Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
[TBL] [Abstract][Full Text] [Related]
27. Postoperative radiotherapy for advanced medullary thyroid cancer--local disease control in the modern era.
Schwartz DL; Rana V; Shaw S; Yazbeck C; Ang KK; Morrison WH; Rosenthal DI; Hoff A; Evans DB; Clayman GL; Garden AS; Sherman SI
Head Neck; 2008 Jul; 30(7):883-8. PubMed ID: 18213725
[TBL] [Abstract][Full Text] [Related]
28. Importance of lymph node metastases in follicular thyroid cancer.
Witte J; Goretzki PE; Dieken J; Simon D; Röher HD
World J Surg; 2002 Aug; 26(8):1017-22. PubMed ID: 12045860
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
[TBL] [Abstract][Full Text] [Related]
30. [Thyroid cancers].
Mogoş V; Zbranca E; Strat V; Diaconescu MR; Chifan M; Florea N; Costăchescu G; Găleşanu MR; Rusu V; Georgescu G
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):72-81. PubMed ID: 9524659
[TBL] [Abstract][Full Text] [Related]
31. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma in Hong Kong Chinese patients.
Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
[TBL] [Abstract][Full Text] [Related]
33. [Medullary thyroid carcinoma: prognostic factors].
Pelizzo MR; Busnardo B; Bernante P; Girelli ME; Nacamulli D; Toniato A; Piotto A
Minerva Chir; 1993 Nov; 48(21-22):1289-91. PubMed ID: 8152559
[TBL] [Abstract][Full Text] [Related]
34. Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.
Kandil E; Gilson MM; Alabbas HH; Tufaro AP; Dackiw A; Tufano RP
Ann Surg Oncol; 2011 Apr; 18(4):1028-34. PubMed ID: 21046269
[TBL] [Abstract][Full Text] [Related]
35. Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival.
Hyer SL; Vini L; A'Hern R; Harmer C
Eur J Surg Oncol; 2000 Nov; 26(7):686-90. PubMed ID: 11187027
[TBL] [Abstract][Full Text] [Related]
36. Different outcomes in sporadic versus familial medullary thyroid cancer.
Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M
Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085
[TBL] [Abstract][Full Text] [Related]
37. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
[TBL] [Abstract][Full Text] [Related]
38. Radioactive iodine treatment in medullary thyroid carcinoma.
Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
[TBL] [Abstract][Full Text] [Related]
39. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
Machens A; Lorenz K; Dralle H
Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
[TBL] [Abstract][Full Text] [Related]
40. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.
Bhattacharyya N
Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
